Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
5.74
+0.14 (2.50%)
Nov 21, 2024, 1:19 PM EST - Market open
Terns Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | -88.07 | -90.21 | -60.35 | -50.16 | -29.35 | -68.61 | Upgrade
|
| Depreciation & Amortization | 0.9 | 0.88 | 1.03 | 0.51 | 0.39 | 0.2 | Upgrade
|
| Loss (Gain) From Sale of Investments | -2.43 | -5.03 | 0.08 | 0.88 | 0.04 | -0.04 | Upgrade
|
| Stock-Based Compensation | 15.89 | 25.54 | 10.77 | 8.15 | 1.69 | 0.67 | Upgrade
|
| Other Operating Activities | 0.15 | 0.14 | 0.39 | 0.22 | -7.64 | -0.3 | Upgrade
|
| Change in Accounts Payable | -1.59 | 1.15 | -0.72 | 1.73 | -1.15 | 0.72 | Upgrade
|
| Change in Other Net Operating Assets | 0.41 | 0.14 | -0.32 | -3.15 | 6.21 | 1.15 | Upgrade
|
| Operating Cash Flow | -74.75 | -67.39 | -49.11 | -41.83 | -29.81 | -66.22 | Upgrade
|
| Capital Expenditures | -0.09 | -0.05 | -0.28 | -0.34 | -0.58 | -0.9 | Upgrade
|
| Investment in Securities | 129.26 | -37.94 | -22 | -119.36 | 7.28 | -2.96 | Upgrade
|
| Investing Cash Flow | 129.17 | -37.99 | -22.27 | -119.7 | 6.69 | -3.86 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 16.88 | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 0.06 | Upgrade
|
| Total Debt Issued | - | - | - | - | 16.88 | 0.06 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -12.88 | - | - | Upgrade
|
| Total Debt Repaid | - | - | - | -12.88 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -12.88 | 16.88 | 0.06 | Upgrade
|
| Issuance of Common Stock | 177.63 | 42.3 | 167.5 | 137.28 | 0.12 | 0.03 | Upgrade
|
| Other Financing Activities | -0.08 | -0.34 | -0.4 | 10 | -0.86 | -0.02 | Upgrade
|
| Financing Cash Flow | 177.55 | 41.95 | 167.1 | 134.39 | 85.52 | 0.06 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.27 | 0.12 | -0.18 | -0.03 | 0.08 | -0.13 | Upgrade
|
| Net Cash Flow | 232.24 | -63.31 | 95.54 | -27.16 | 62.48 | -70.15 | Upgrade
|
| Free Cash Flow | -74.83 | -67.44 | -49.38 | -42.17 | -30.39 | -67.12 | Upgrade
|
| Free Cash Flow Margin | - | - | - | -4216.70% | - | - | Upgrade
|
| Free Cash Flow Per Share | -1.00 | -0.95 | -1.37 | -1.86 | -106.58 | -366.26 | Upgrade
|
| Cash Income Tax Paid | 0.03 | 0.03 | 0 | 0.24 | 0.18 | 0.07 | Upgrade
|
| Levered Free Cash Flow | -45.9 | -36.12 | -27.38 | -10.9 | -30.09 | -20.44 | Upgrade
|
| Unlevered Free Cash Flow | -45.9 | -36.12 | -27.38 | -10.9 | -30.09 | -20.44 | Upgrade
|
| Change in Net Working Capital | 0.11 | -1.61 | 0.14 | -11.95 | 8.45 | -1.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.